The Effect of Eight Weeks of moderate Intensity Continuous training with sodium alginate supplementation on PYY and Lipid Profile Levels in Men with Metabolic Syndrome.
Poster Presentation XML
Paper ID : 1400-12THCONG
Oral / Poster Presentation File:
phisilogy, faculity of sprrt siencince, kermanshah, Iran
Metabolic syndrome is a cluster of metabolic abnormalities that increase the risk of mortality and chronic kidney disease, type 2 diabetes and cardiovascular disease.
The purpose of the present study was to determine the effect of 8 weeks of moderate-intensity Continuous training(MICT) on PYY levels in men with metabolic syndrome.
Method: For this purpose, Twenty-four male students with metabolic syndrome from Razi University students were randomly divided into three equal groups, MICT with supplement (n=8, 30mins at 60-70% HRpeak,3x/week), MICT with placebo (n=8, 30mins at 60-70% HRpeak,3x/week) and control group (n = 8, no exercise) were divided. The appetite status of the subjects was measured using a questionnaire (VAS) at the first session and the last training session. The PYY and metabolic syndrome risk factors (waist circumference ≥102 cm, HDL-C≤40mg, triglycerides≥ 150 mg /dl), blood pressure ≥130/85 mm Hg, fasting blood glucose≥ 100 mg/dL were measured at the beginning and the end of the study Blood samples were collected 48 h before and 48 h after the last training session. Data were analyzed by SPSS software version 16 using t-test correlation and one-way variance analysis of variance.
Result: Results showed that PYY significantly increased in all two training. This increase was significantly greater in the MICT + supplemented group than the other groups (P <0 05). Also, the metabolic syndrome Z score was significantly decreased in all experimental groups and this decrease was significantly higher in the MICT +supplemented group than the other groups (P <0 05).

It can be concluded that 8 weeks of MICT+ supplemented, MICT+ placebo has a significant effect on appetite, appetite hormones and metabolic syndrome factors, with a greater improvement in the MICT+ supplement group.